Note: Single-source report; awaiting corroboration.
A research group supported by the National Institutes of Health (NIH) has introduced an open-access tool to improve the management of amblyopia in children. Amblyopia, caused by improper visual development in one or both eyes early in life, affects about three in every 100 U.S. children and is the leading cause of preventable single-eye vision loss. The tool addresses the shortage of pediatric eye care specialists by offering clinicians evidence-based, individualized diagnostic and treatment support for amblyopia via an online platform.
The condition can result from misaligned eyes (strabismus), significant differences in prescription strength between eyes, the need for stronger prescriptions in both eyes, or obstructions such as cataracts or drooping eyelids. Untreated amblyopia can lead to permanent vision loss that glasses or contact lenses cannot correct in adulthood. It may also impact educational performance, employment, quality of life, and increase vulnerability to further vision loss.
Treatment for amblyopia is generally effective and often restores vision to near-normal levels. Early detection yields the best results, but improvement is possible at any age with multiple treatment options available. The new Amblyopia Navigator Decision-Support Instrument (ANDI) guides eye care providers through diagnosis and treatment decisions based on current literature. ANDI is available online for those with internet access and provides printable reference sheets for offline use.
Researchers note significant geographic variation in the availability of pediatric optometrists and ophthalmologists in the U.S., with some states lacking specialists entirely. The tool aims to reduce access gaps and provide clinical decision-making support more broadly.
Researchers hope ANDI will support clinicians everywhere and improve pediatric amblyopia care across diverse settings.